Effector cell activation through IDO vaccination may not only eliminate the antigen-expressing tumor cells but may also induce immunological activation through the simultaneous enhancement of other effector responses and reduced regulatory signals [12,13,17]. The gene discussed is IDO1; the disease is neoplasm.